• About us
• Contact

Advertisement

Organisation › Details

Bayer-Tsinghua Joint Research Center for Innovative Drug Discovery (BTC)

In 2009, Bayer HealthCare established a strategic partnership with the Tsinghua University - Institute of Biomedicine. Driven by their joint interest to improve treatment options for patients through innovation, the two partners established the "Bayer-Tsinghua (Institute of Biomedicine) Joint Research Center for Innovative Drug Discovery" (BTC). The center is headed by Professor Shi Yigong, Dean of School of Life Sciences, Tsinghua University. *

 

	Start	2009-01-01 established
	Group	Bayer (Group)
	Industry	drug discovery
	Region	Beijing (Peking)
	Country	China
	City	n. a. Beijing
		Address record changed: 2012-03-29
Basic data	Employees	n. a.
		* Document for »About Section«:
		Record changed: 2023-07-10

Advertisement

More documents for Bayer (Group)

• [1] Boundless Bio, Inc.. (5/16/23). "Press Release: Boundless Bio Announces $100 Million Oversubscribed Series C Financing Co-led by Leaps by Bayer and RA Capital Management". San Diego, CA....
• [2] ReCode Therapeutics. (6/29/22). "Press Release: ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M". Menlo Park, CA & Dallas, TX....
• [3] Bayer AG. (4/13/22). "Press Release: Bayer Receives Approval for Precision Oncology Treatment Vitrakvi in China [Not intended for U.S. and UK Media]". Berlin....
• [4] Bayer AG. (5/27/21). "Press Release: Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health". Leverkusen, Berlin & Whippany....
• [5] BlueRock Therapeutics LP. (5/17/21). "Press Release: BlueRock Therapeutics, Fujifilm Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases". Cambridge, MA & Madison, WI....
• [6] Vividion Therapeutics, Inc.. (2/24/21). "Press Release: Vividion Announces $135 Million Series C Financing to Fuel Broad Pipeline of Precision Oncology and Immunology Programs". San Diego, CA....
• [7] Bayer AG. (1/6/21). "Press Release: Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform". Leverkusen & South San Francisco, CA....
• [8] Bayer AG. (9/10/20). "Press Release: Bayer – Supervisory Board Extends CEO Werner Baumann’s Contract until the End of April 2024. Company also Announces Progress in Roundup Settlements". Leverkusen....
• [9] Bayer AG. (8/27/20). "Press Release: Bayer and Northpond Ventures Lead USD 55 Million Series A Financing Round for Triumvira Immunologics". Leverkusen & Austin, TX....
• [10] Bayer AG. (8/27/20). "Press Release: Bayer Receives Approval for Xofigo in China [Not intended for U.S. and UK Media]". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.